The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.
about
Cardiac device implantation in Fabry disease: A retrospective monocentric study.Cardiac Phenotype of Prehypertrophic Fabry Disease.Limited effects of long-term enzyme replacement therapy on the cardiac conduction system in Fabry diseaseHeterozygous junctophilin-2 (JPH2) p.(Thr161Lys) is a monogenic cause for HCM with heart failure
P2860
The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.
@en
The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.
@nl
type
label
The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.
@en
The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.
@nl
prefLabel
The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.
@en
The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.
@nl
P2093
P2860
P1433
P1476
The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.
@en
P2093
Albina Nowak
Andreas Brauchlin
Christian Schmied
Christiane Gruner
Dipen Shah
Eric Olinger
Frédéric Barbey
Huguette Debaix
Mehdi Namdar
Michelle Frank
P2860
P304
P356
10.1136/HEARTJNL-2015-308897
P407
P577
2016-04-07T00:00:00Z